Zheng-Qi Song1, Yu-Peng Xu2, Yi-Qi Chen3

  • 1Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang, Wenzhou, Zhejiang, China; The First Clinical Medical College, Wenzhou Medical University, Chashan, Wenzhou, Zhejiang, China.

Journal of cardiology
|July 22, 2025
PubMed
概括

这项研究确定了心脏导电障碍 (CCD) 的新型蛋白质标,包括CASP9和ASPH,为治疗提供了新的途径. 它还揭示了潜在的生物机制,如高血症,是CCD发展的基础.